These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30431665)

  • 1. Acute myeloid leukemia with minimal differentiation (AML M0) mimicking acute lymphoblastic leukemia.
    Shanmugam V; Dorfman DM
    Am J Hematol; 2019 Aug; 94(8):955-956. PubMed ID: 30431665
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood T-acute lymphoblastic leukemia relapsed as minimally differentiated acute myeloid leukemia (AML-M0).
    Ortín X; Escoda L; Nomdedeu J; Llorente A; Cabezudo E; Boixadera J; Ugarriza A
    Leuk Lymphoma; 2003 Dec; 44(12):2159-61. PubMed ID: 14959865
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia.
    Liu K; Zhou F; Fu Z; Yin J; Li W
    Indian J Pathol Microbiol; 2018; 61(3):464-467. PubMed ID: 30004087
    [No Abstract]   [Full Text] [Related]  

  • 4. p-Iodophenol-enhanced luminol chemiluminescent assay applied to discrimination between acute lymphoblastic and minimally differentiated acute myeloid (FAB-M0) or acute megakaryoblastic (FAB-M7) leukemias.
    da Costa M; Ximenes VF; Brunetti IL; Falcão RP; da Fonseca LM
    Hematol J; 2004; 5(6):496-9. PubMed ID: 15570291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current diagnosis of acute leukemia (lecture)].
    Frenkel' MA
    Klin Lab Diagn; 1999 Jan; (1):25-32. PubMed ID: 10097492
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granular acute lymphoblastic leukemia in an adult patient.
    Anand H; Tyagi S
    Indian J Pathol Microbiol; 2008; 51(1):116-7. PubMed ID: 18417880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
    Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
    Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally differentiated acute myelogenous leukemia (AML-M0) granulocytic sarcoma presenting in the oral cavity.
    Amin KS; Ehsan A; McGuff HS; Albright SC
    Oral Oncol; 2002 Jul; 38(5):516-9. PubMed ID: 12110349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometry of bone marrow cells in health, anemias of different etiology and acute leukemias].
    Shmarov DA; Kuchma IuM; Kozinets GI
    Klin Lab Diagn; 1997 Oct; (10):3-5. PubMed ID: 9417320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brazilian group of flow cytometry (GBCFLUX) panels for acute leukemia: Some insights.
    Matos DM
    Cytometry B Clin Cytom; 2015; 88(5):286-7. PubMed ID: 26235996
    [No Abstract]   [Full Text] [Related]  

  • 13. Flow cytometry in the post fluorescence era.
    Nolan GP
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):505-8. PubMed ID: 22127312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of three-color flow cytofluorometry in the algorithm for detection of minimal residual disease in children with acute lymphoblastic and acute myeloblastic leukemia].
    Savva NN; Belevtsev MV; Savitskiĭ VP; Migal' NV; Movchan LV; Aleĭnikova OV
    Klin Lab Diagn; 2009 Dec; (12):15-8. PubMed ID: 20140998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML-M0: a review of laboratory features and proposal of new diagnostic criteria.
    Stasi R; Amadori S
    Blood Cells Mol Dis; 1999 Apr; 25(2):120-9. PubMed ID: 10389594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
    Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine and adhesion molecule profile differs in newly diagnosed acute myeloid and lymphoblastic leukemia.
    Horacek JM; Kupsa T; Vasatova M; Jebavy L; Zak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):299-301. PubMed ID: 25363727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.